News Details

(As on May 26, 2025, 10:19)

Back

Cohance Lifesciences gets USFDA EIR for Telangana Unit; Tagged VAI

Cohance Lifesciences Limited has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its API Unit-IV, located at Plot No. A-21, Road No. 10, IDA Nacharam, Uppal Mandal, Medchal-Malkajgiri, Telangana.

The inspection was conducted from March 3 to March 7, 2025, and has been classified as "Voluntary Action Indicated" (VAI), signifying the formal closure of the inspection process by the USFDA.

The company reiterated its commitment to upholding the highest standards of quality and regulatory compliance across all its operations.

ATTENTION INVESTORS

"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)

Designed, developed and content provided by

News

News Details

SMS Registration

Mobile Trading

Investors Grievances

Invest By QFI

CLIENT LOGIN

FRANCHISEE LOGIN

INTERNET TRADING